Your free source for Life Science Regulatory Compliance documents.
FDA GFI, Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing, 06/20
FDA GFI, Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing, 06/20
Anna Sandberg2021-09-29T13:11:30+00:00September 29th, 2021|